Cargando…

Clinical implications of metastatic lymph node ratio in gastric cancer

BACKGROUND: The 5-year survival rate in patients with gastric cancer is still poor, and lymph node metastasis is considered one of the most important prognostic factors. However, there are controversies in the classification of lymph node metastasis in gastric cancer. This study was carried out to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Caigang, Lu, Ping, Lu, Yang, Xu, Huimian, Wang, Shubao, Chen, Junqing
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194781/
https://www.ncbi.nlm.nih.gov/pubmed/17958880
http://dx.doi.org/10.1186/1471-2407-7-200
_version_ 1782147693943980032
author Liu, Caigang
Lu, Ping
Lu, Yang
Xu, Huimian
Wang, Shubao
Chen, Junqing
author_facet Liu, Caigang
Lu, Ping
Lu, Yang
Xu, Huimian
Wang, Shubao
Chen, Junqing
author_sort Liu, Caigang
collection PubMed
description BACKGROUND: The 5-year survival rate in patients with gastric cancer is still poor, and lymph node metastasis is considered one of the most important prognostic factors. However, there are controversies in the classification of lymph node metastasis in gastric cancer. This study was carried out to investigate whether the metastatic lymph node ratio is a reliable classification of lymph node metastasis in gastric cancer in Chinese. METHODS: 224 cases with gastric cancer with more than D1 dissection were retrospectively reviewed. The association between the total number of resected lymph nodes and the number of metastatic lymph nodes was determined. The prognostic value of the metastastic node ratio, defined as the ratio of the number of metastatic lymph nodes over the total number of resected lymph nodes, and the pN classification was assessed. RESULTS: The number of metastatic lymph node increased with the number of total resected lymph nodes. A Cox regression revealed that the metastatic node ratio, the number of metastatic nodes, histological type, and histological growth pattern independently influenced prognosis. The 5-year survival rates were 78%, 61%, 25%, 0% in cases with a metastastic node ratio of 0%, > 0% but < 40%, 40–80%, > 80%, respectively (P < 0.001), and were 78%, 62%, 38%, 0% in cases with gastric cancer histologically classified as pN0, pN1, pN2, pN3, respectively (P < 0.001). CONCLUSION: The metastatic lymph node ratio is a simple and useful independent prognostic factor. It may obviate possible confounding factors that are related to stage migration, and should be considered as an important component in the lymph node category.
format Text
id pubmed-2194781
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-21947812008-01-13 Clinical implications of metastatic lymph node ratio in gastric cancer Liu, Caigang Lu, Ping Lu, Yang Xu, Huimian Wang, Shubao Chen, Junqing BMC Cancer Research Article BACKGROUND: The 5-year survival rate in patients with gastric cancer is still poor, and lymph node metastasis is considered one of the most important prognostic factors. However, there are controversies in the classification of lymph node metastasis in gastric cancer. This study was carried out to investigate whether the metastatic lymph node ratio is a reliable classification of lymph node metastasis in gastric cancer in Chinese. METHODS: 224 cases with gastric cancer with more than D1 dissection were retrospectively reviewed. The association between the total number of resected lymph nodes and the number of metastatic lymph nodes was determined. The prognostic value of the metastastic node ratio, defined as the ratio of the number of metastatic lymph nodes over the total number of resected lymph nodes, and the pN classification was assessed. RESULTS: The number of metastatic lymph node increased with the number of total resected lymph nodes. A Cox regression revealed that the metastatic node ratio, the number of metastatic nodes, histological type, and histological growth pattern independently influenced prognosis. The 5-year survival rates were 78%, 61%, 25%, 0% in cases with a metastastic node ratio of 0%, > 0% but < 40%, 40–80%, > 80%, respectively (P < 0.001), and were 78%, 62%, 38%, 0% in cases with gastric cancer histologically classified as pN0, pN1, pN2, pN3, respectively (P < 0.001). CONCLUSION: The metastatic lymph node ratio is a simple and useful independent prognostic factor. It may obviate possible confounding factors that are related to stage migration, and should be considered as an important component in the lymph node category. BioMed Central 2007-10-24 /pmc/articles/PMC2194781/ /pubmed/17958880 http://dx.doi.org/10.1186/1471-2407-7-200 Text en Copyright © 2007 Liu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Liu, Caigang
Lu, Ping
Lu, Yang
Xu, Huimian
Wang, Shubao
Chen, Junqing
Clinical implications of metastatic lymph node ratio in gastric cancer
title Clinical implications of metastatic lymph node ratio in gastric cancer
title_full Clinical implications of metastatic lymph node ratio in gastric cancer
title_fullStr Clinical implications of metastatic lymph node ratio in gastric cancer
title_full_unstemmed Clinical implications of metastatic lymph node ratio in gastric cancer
title_short Clinical implications of metastatic lymph node ratio in gastric cancer
title_sort clinical implications of metastatic lymph node ratio in gastric cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194781/
https://www.ncbi.nlm.nih.gov/pubmed/17958880
http://dx.doi.org/10.1186/1471-2407-7-200
work_keys_str_mv AT liucaigang clinicalimplicationsofmetastaticlymphnoderatioingastriccancer
AT luping clinicalimplicationsofmetastaticlymphnoderatioingastriccancer
AT luyang clinicalimplicationsofmetastaticlymphnoderatioingastriccancer
AT xuhuimian clinicalimplicationsofmetastaticlymphnoderatioingastriccancer
AT wangshubao clinicalimplicationsofmetastaticlymphnoderatioingastriccancer
AT chenjunqing clinicalimplicationsofmetastaticlymphnoderatioingastriccancer